Please enable Javascript
Ajay K. Singh, MBBS, FRCP, MBA
Articles by Ajay K. Singh, MBBS, FRCP, MBA
Cardiovascular-Kidney-Metabolic Syndrome: A New Look for an Old Syndrome
Ajay K. Singh, MBBS, FRCP, MBA
From the Chair
|
November 13, 2023
SGLT2i therapy is contraindicated in patients with type 1 diabetes mellitus (T1DM) who have CKD.
Read More
Support the Chronic Kidney Disease Improvement in Research and Treatment Act (HR 5027)
Ajay K. Singh, MBBS, FRCP, MBA
From the Chair
|
October 26, 2023
The first part of the dialysis moonshot is to prevent the need for dialysis.
Read More
UACR: Its Time Has Come
Ajay K. Singh, MBBS, FRCP, MBA
From the Chair
|
September 18, 2023
Measuring eGFR and UACR is a key component of guideline-directed medical therapy for patients with CKD from type 2 diabetes.
Read More
SGLT2 Inhibitors and CKD
Ajay K. Singh, MBBS, FRCP, MBA
From the Chair
|
August 9, 2023
The most important patients who should receive treatment with SGLT2 inhibitors are those with CKD and type 2 diabetes.
Read More
New Treatment for Lupus Nephritis
Ajay K. Singh, MBBS, FRCP, MBA
From the Chair
|
December 22, 2020
Editor's Note: ...
Read More